SV Biotech Crossover Opportunities Fund Discloses 7.0% Stake in TRex Bio
The fund acquired 957,143 shares in TRex Bio’s Oct. 8 IPO and received 963,524 preferred shares upon their conversion at the Oct. 13 closing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.